We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
153 result(s) found, displaying 1 to 10
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METALYSE tenecteplase (rch) 25 mg powder for injection vial.
-
Prescription medicine registrationActive ingredients: Tenecteplase.
-
Prescription medicine registrationActive ingredients: empagliflozin.
-
Prescription medicine registrationActive ingredients: empagliflozin, metformin hydrochloride.
-
Australian public assessment report (AusPar)Jardiance (empagliflozin) has been approved for reducing the risk of kidney disease progression in adults with chronic kidney disease.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial.
-
Australian public assessment report (AusPar)Spevigo (spesolimab) has been approved for the treatment of generalised pustular psoriasis, a rare but severe form of psoriasis that involves flares of widespread, non-infectious, macroscopically visible pustules.
-
Prescription medicine registrationActive ingredients: empagliflozin.